Balansag, Rodelia B.
HRN: 08-69-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/04/2024
07/10/2024
IV DRIP
4.5g Then 2.25g
As LD Then Q8
DM Foot
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes